On Thursday, October 30, 2025, Sagility shares jumped over 10%, hitting a high of ₹56, after the company reported great financial results for Q2 FY26. Investors were happy with the Bengaluru company’s awesome numbers, which showed big growth in revenue, profit, and margins—all thanks to the company’s strong business and how well it’s running things.
Sagility Q2 FY26 Results: Profit Up 114.5% Year Over Year
Sagility’s total net profit went up a huge 114.5% from last year, reaching ₹251 crore in the July–September quarter of FY26, compared to ₹117 crore last year. This big growth in earnings shows that the company is managing costs well and running things efficiently.
The company’s revenue went up 25% from last year, hitting ₹1,658 crore in Q2 FY26, from ₹1,325 crore in Q2 FY25, which is another quarter of strong revenue growth.
EBITDA and Margins Show Good Improvement
Sagility’s EBITDA rose 38% from last year to ₹416 crore, from ₹301 crore in Q2 FY25. The EBITDA margin went up to 25.06%, compared to 22.72% last year, which means the company is making more money and running things better.
Sarvabhouman Srinivasan, Group CFO of Sagility, said about the results:
“Our margins are still good along with strong growth because we’re keeping costs down and running things well. We’re still working on keeping a good balance sheet and putting money into AI to help our healthcare workforce in the future.”
H1 FY26 Performance: Growth All Around
In the first half (H1) of FY26, Sagility’s revenue was ₹3,197 crore, up 25.5% from last year (21.4% without currency changes). Organic revenue grew 16.9% from last year (13.2% without currency changes), showing that the company can keep up its business growth.
The company’s adjusted EBITDA was ₹804 crore (US$93 million), which is 25.1% of revenue, up 26% from last year. Adjusted PAT jumped 62.4% from last year to ₹501 crore (US$57.9 million), with a good 15.7% profit margin.
Earnings per share (EPS) for H1 FY26 was ₹0.85, up 178.3% from last year—a great achievement showing how the company is making money for shareholders.
Dividend Announcement and Outlook
Sagility also announced an interim dividend of ₹0.05 per share (face value ₹10 each) for FY26. The record date is November 12, 2025, and the dividend will be paid by November 28, 2025. This payment shows that the company is confident in its cash flow and financial stability.
Leadership Commentary and Direction
Ramesh Gopalan, Managing Director & Group CEO of Sagility, said that the company is focusing on changing service models:
“Our performance in the first half of FY26 shows that Sagility can keep growing in a changing market. As clients have money problems, we’re using our knowledge and skills to help them save money.”
He added that Sagility’s client deals are changing from traditional service to outcome-based models, focusing on cost savings and long-term value.
Sagility Share Price and Market Performance
At 10:20 AM, Sagility shares were trading at ₹53.75 on NSE, up 5.66% for the day. The stock has been doing well recently—up 13% in the last five days, over 26% in the last month, and a huge 32.5% in six months. Since the start of 2025, Sagility’s stock has gone up 13.6%, showing that investors are more confident in the company.
As of September 30, 2025, Sagility had 44,185 employees and 34 delivery centers in five countries, which helps it grow its global presence in healthcare business process management (BPM) services.
In Conclusion: Sagility Keeps Growing
With great Q2 numbers, growing margins, and a strong balance sheet, Sagility is in a good spot for long-term growth. It focuses on AI, cost savings, and putting clients first, which is helping it make money and making investors happy.
For investors looking for long-term potential in healthcare BPM and AI., Sagility shares offer a compelling growth story backed by solid fundamentals and consistent execution.
Note: All information and images used in this content are sourced from Google. They are used here for informational and illustrative purposes only.
FAQs on Sagility Shares Rally After Strong Q2 FY26 Results
What caused the shares to rally over 10% on October 30, 2025?
The stock surged over 10% after the company reported strong Q2 FY26 results, showcasing a 114.5% jump in net profit and a 25% increase in revenue, reflecting robust operational performance and investor confidence.
What was the company’s net profit for Q2 FY26?
The consolidated net profit rose sharply to ₹251 crore in Q2 FY26, compared to ₹117 crore in the same quarter of the previous year, marking an impressive 114.5% year-on-year growth.
What was the revenue growth during Q2 FY26?
Revenue from operations climbed 25% year-on-year to ₹1,658 crore in Q2 FY26, up from ₹1,325 crore in Q2 FY25, driven by strong business momentum and expanding client engagements.
What were the EBITDA and margin performance in Q2 FY26?
EBITDA stood at ₹416 crore for Q2 FY26, up 38% from ₹301 crore in Q2 FY25. The EBITDA margin expanded to 25.06%, compared to 22.72% a year earlier, indicating improved operational efficiency.
What did the management say about Q2 FY26 performance?
Group CFO Sarvabhouman Srinivasan said the strong performance reflects disciplined cost management, operational efficiency, and sustained investment in AI-driven, healthcare-centric growth.
What were the H1 FY26 financial highlights?
For the first half of FY26, revenue reached ₹3,197 crore, up 25.5% year-on-year. Adjusted EBITDA stood at ₹804 crore, while adjusted PAT rose 62.4% to ₹501 crore, reflecting consistent financial growth.
What was the earnings per share (EPS) in H1 FY26?
The basic EPS increased 178.3% year-on-year to ₹0.85 per share, indicating strong profitability and improved shareholder returns.
What dividend was declared for FY26?
An interim dividend of ₹0.05 per share (face value ₹10 each) was declared. The record date is November 12, 2025, and payment will be made on or before November 28, 2025.
What did CEO Ramesh Gopalan say about the company’s outlook?
He stated that the performance highlights the company’s ability to deliver sustainable growth while helping clients manage profitability pressures through efficiency-driven solutions.
What is the workforce and global presence as of September 2025?
As of September 30, 2025, the company employed 44,185 professionals and operated 34 delivery centers across five countries, strengthening its position in global healthcare business process management.
How has the share price performed recently?
At 10:20 AM on October 30, 2025, shares were trading at ₹53.75 on NSE, up 5.66%. Over the last five sessions, the stock gained 13%, climbed 26% in a month, and rose 32.5% over six months.
Why are investors optimistic about the company’s future?
Optimism stems from consistent revenue growth, strong profit expansion, healthy margins, and strategic investments in technology, AI, and healthcare-focused solutions ensuring long-term sustainability.
Which factors make it an attractive investment option?
The firm’s focus on operational efficiency, strong cash flow generation, margin expansion, and AI-driven transformation in the healthcare sector make it a compelling long-term investment choice.
Leave a Reply